Internal Medicine, Cardiovascular Disease · San Mateo, CA
NPI
1093726895
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
100 S San Mateo Dr, Suite 400
San Mateo, CA, 94401
Phone (650) 696-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
2,474 services
Medicare patients, 2024
1,301
Average age 78
Drug cost, 2024
$1.6M
11,623 prescriptions
Company payments, 2025
$3,458
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey J Guttas was code 99214 (office e&m - established), 1,257 times for 731 patients. In total Jeffrey J Guttas billed 2,474 services in 35 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,257 | 731 | $110.46 | $139K |
| 93000 Electrocardiogram | Office | 169 | 147 | $12.95 | $2,188 |
| 99213 Office E&M - Established | Office | 122 | 112 | $79.08 | $9,647 |
| 99204 Office E&M - New | Office | 121 | 121 | $147.26 | $18K |
| 93010 Electrocardiogram | Facility | 95 | 87 | $7.21 | $685 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 84 | 83 | $195.86 | $16K |
| 93970 Duplex Scan - Extremity Veins | Facility | 82 | 80 | $28.79 | $2,361 |
| 93978 Duplex Scan - Extremity Arteries | Office | 73 | 73 | $175.64 | $13K |
| 93306 Echocardiography (TTE/TEE) | Facility | 73 | 71 | $61.78 | $4,510 |
| 93306 Echocardiography (TTE/TEE) | Office | 65 | 64 | $193.38 | $13K |
| 93971 Duplex Scan - Extremity Veins | Facility | 61 | 61 | $18.61 | $1,135 |
| 99215 Office E&M - Established | Office | 46 | 42 | $160.62 | $7,389 |
| 93350 Echocardiography (TTE/TEE) | Facility | 30 | 30 | $62.06 | $1,862 |
| 93018 Electrocardiogram | Facility | 29 | 29 | $12.56 | $364 |
| 93016 Electrocardiogram | Facility | 29 | 29 | $19.17 | $556 |
By year: 2022 $278K for 2,762 services; 2023 $248K for 2,568 services; 2024 $241K for 2,474 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey J Guttas prescribed most often to Medicare patients was Amlodipine Besylate, with 1,843 prescriptions and refills. In total Jeffrey J Guttas wrote 11,623 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,843 | 5,153 | 502 | $13K |
| Atorvastatin Calcium Generic | 1,036 | 2,952 | 289 | $13K |
| Metoprolol Succinate Generic | 975 | 2,606 | 263 | $13K |
| Rosuvastatin Calcium Generic | 676 | 1,880 | 200 | $12K |
| Bisoprolol Fumarate Generic | 576 | 1,577 | 156 | $21K |
| Spironolactone Generic | 506 | 1,405 | 182 | $5,294 |
| Nebivolol Hcl Generic | 487 | 1,301 | 178 | $27K |
| Eliquis Apixaban | 452 | 1,073 | 131 | $611K |
| Pravastatin Sodium Generic | 358 | 982 | 96 | $4,840 |
| Ezetimibe Generic | 348 | 993 | 106 | $9,776 |
| Torsemide Generic | 326 | 809 | 112 | $6,091 |
| Olmesartan Medoxomil Generic | 324 | 911 | 94 | $6,304 |
| Indapamide Generic | 251 | 701 | 92 | $5,322 |
| Losartan Potassium Generic | 215 | 615 | 66 | $2,420 |
| Xarelto Rivaroxaban | 204 | 508 | 53 | $277K |
Brand drugs: 1,199 claims; generic drugs: 10,424 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey J Guttas $3,458 ($3,458 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novartis Pharmaceuticals Corporation with $387.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $387 |
| Novo Nordisk Inc NVO | 13 | $350 |
| Amgen Inc. AMGN | 13 | $308 |
| Pfizer Inc. PFE | 16 | $301 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $244 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $228 |
| Esperion Therapeutics, Inc. ESPR | 9 | $224 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $224 |
| Chiesi USA, Inc. | 10 | $205 |
| Lilly USA, LLC LLY | 7 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.